Buy
Sell
Share Name Share Symbol Market Type Share ISIN Share Description
Inspiration Healthcare Group Plc LSE:IHC London Ordinary Share GB00BXDZL105 ORD 10P
  Price Change % Change Share Price Shares Traded Last Trade
  0.00 0.0% 65.00 71,181 08:00:00
Bid Price Offer Price High Price Low Price Open Price
64.00 66.00 65.00 65.00 65.00
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Health Care Equipment & Services 17.78 1.13 2.19 29.7 44
Last Trade Time Trade Type Trade Size Trade Price Currency
16:46:27 O 65,000 64.3653 GBX

Inspiration Healthcare (IHC) Latest News

More Inspiration Healthcare News
Inspiration Healthcare Takeover Rumours

Inspiration Healthcare (IHC) Discussions and Chat

Inspiration Healthcare Forums and Chat

Date Time Title Posts
12/8/202012:14Inspiration Healthcare Group plc422
13/5/202009:45IHC Inspiration Health - Ventilators & PPE in the fight against COVID-19160
02/3/201201:13India Hospitality Corporation129
06/4/200908:44IHC - Significant Undervaluation8

Add a New Thread

Inspiration Healthcare (IHC) Most Recent Trades

No Trades
Trade Time Trade Price Trade Size Trade Value Trade Type
View all Inspiration Healthcare trades in real-time

Inspiration Healthcare (IHC) Top Chat Posts

DateSubject
15/8/2020
09:20
Inspiration Healthcare Daily Update: Inspiration Healthcare Group Plc is listed in the Health Care Equipment & Services sector of the London Stock Exchange with ticker IHC. The last closing price for Inspiration Healthcare was 65p.
Inspiration Healthcare Group Plc has a 4 week average price of 60p and a 12 week average price of 57p.
The 1 year high share price is 89.50p while the 1 year low share price is currently 57p.
There are currently 67,973,609 shares in issue and the average daily traded volume is 62,687 shares. The market capitalisation of Inspiration Healthcare Group Plc is £44,182,845.85.
19/6/2020
08:59
lammylover: RNS. IHC conditionally agree to buy SLE Ltd for £18m on a cash free, debt free basis. SLE are a leader in design and manufacture of ventillators for neo natal intensive care. IHC have raised £16.5m from institutional investors at 65p / share and offer PIs the opportunity to purchase shares at 65p on the basis of 1 new share to 50 already held. SLE Ltd purchase is expected to be earnings enhancing in the short to medium term and also raises profile of IHC. Good news, particularly that they have raised capital at almost the current share price with just 1.5% discount! Rich
20/5/2020
14:41
hedgehog 100: The GDR (Genedrive) share price has risen over fifteen-fold since March, from under 10p to over 150p, fuelled substantially by the potential for the COVID-19 tests that it is developing. In view of IHC's existing distribution relationship with GDR, IHC could potentially be used as distributor for these tests. 24/04/2020 07:00 UKREG Genedrive PLC Distribution agreement for AIHL test 24/04/2020 07:00 UKREG Inspiration Healthcare Group PLC Distribution agreement for AIHL test https://uk.advfn.com/stock-market/london/inspiration-healthcare-IHC/share-news/Inspiration-Healthcare-Group-PLC-Distribution-agre/82298622
12/5/2020
16:18
lammylover: MMs keep walking the bid price down, even though there are more buys than sells. They are just trying to shake out the weaker hands around 57-62p and acquire more shares at rock bottom prices. Share price will motor up eventually, once this source of cheap shares dries up and they can then walk it up to 70p and beyond to generate bigger volumes and commission. Rich
05/5/2020
20:09
vprt: Hi troutisout: I'm not an expert on investment trusts and have not spent time pondering such "what if" questions (as I don't own MINI) - others might have better views on that. But I don't think an annual redemption clause is a standard thing, and possibly quite unusual. The point is that I believe there is quite some risk of IHC shares being sold in the market, but it is unclear how many, and how gently/slowly or brutally/quickly this will happen. Miton give themselves lots of leeway on the "how", as the following extract from the RNS illustrates. (It seems to me that they are trying to shelter long term holders i.e. those who are not redeeming by letting the "Redemption Pool" take most of the pain from any low-valued sales, if they choose to carve up the assets in advance in that way): "Shareholders submitting valid requests for the redemption of Ordinary Shares will have their shares redeemed at the Redemption Price which is calculated on either of the following bases: I. The Directors may elect to divide each of the Company's portfolio holdings in proportion to the percentage of shareholders opting for redemption and set them aside in a Redemption Pool to be sold via the stock market. When complete, the realisation proceeds after deduction of costs would be distributed to shareholders pro rata. It should be noted that the liquidation of a Redemption Pool can be expected to take some weeks or months, and the final capital sum may not amount to the initial valuation of the Redemption Pool. As highlighted in the Company's Half Year Report, published on 13 December 2019, shareholders should note that this is the method most likely to be used; or II. If the percentage of the Company's shares that opt for redemption is a modest proportion of the Company the Directors can set a Redemption Price that is equal to the Net Asset Value per Ordinary Share (including current period revenue) (the "Dealing Value") prevailing on the last business day prior to the Redemption Point. The Directors may elect, at their absolute discretion, to calculate the Redemption Price on the bases set out above, or the Company may arrange for such shares to be sold in the market at the Dealing Value (subject to the Directors' discretion). At the date of writing the share price of the Company is standing at a discount to the Net Asset Value, and if this was the case at the Redemption Point, then it is unlikely that there would be willing buyers of the redeemed shares at the Dealing Value. The Directors are minded to approve all redemption requests unless there are exceptional reasons why this would be contrary to the interests of all shareholders. " ...
21/4/2020
11:40
lammylover: IHC issue 2nd RNS of FY results to end January 2020 - looks like the BOD were shocked by share price drop this morning and have tried to rehash the format of the results to highlight the many positives from LY. Could do with up to date info on current situation with sales revenue (including one off ventilator orders)for this year. Rich
21/4/2020
08:44
lammylover: RNS FY to end Jan 2020 Revenue up 15% to £17.8m Like for like revenue up 12% Gross margin up from 45.5% to 48.2% Operational profit up 24% to £1.5m Profit before tax £1.1m (was £1.2m last year) after exceptional items Viomedex performed in line in 4 months since acquisition Cash £4.5m Market value at 64p is £24.5m RNS needed more info on outlook / update - IHC received £5m one off orders in first quarter which were hardly mentioned, hence drop in share price this morning. Needs some good media coverage in Shares / Investors Chronicle to get more bargain hunting buyers. Rich
07/4/2020
16:38
lammylover: I think its just PIs expecting too much. Those who bought in around mid 60s, expected instant surge in share price on additional orders. People are not prepared to wait a week or two for results to come out (approx. 20th April, by my reckoning) and move money elsewhere as every other share seems to have surged in price the last 2 days. Happy to hold for results - lets face it, IHC revenue must be up on increased demand and EBITDA the same. I can't see a reduction in demand for medical items in the near future, the only risk is if they can't supply enough due to global demand. The current share price doesn't include any uplift for the £4m ventilator order - in fact share price hit 72p before the 2 orders in March. Just my take on things - patience is a virtue! The market transfers money from the impatient to the patient - Warren Buffett
07/4/2020
13:57
geovest: Don't blame the MM's or institutional investors. It is probably private investors bailing out because the share price didn't double as they expected, now they are selling out at a loss. MM's and II's know how companies are valued, most PI's don't. A simple way to look at it is: The value of a company is the discounted cashflow of all future earnings. A huge £4m order for ventilators is a one-off event, it changes the value of the company only to the extent of the one-off profit. As they act as distributor, their profit margin is probably below 10%. If we are generous, that's £400k profit. The current market Cap for the company is £25m. So, this order, if delivered in full, would increase that by £400k or 1.6%. The share price before the announcement was 64p. The order could only ever have added 1p to the share price, but unrealistic expectations and lack of understanding pushed the price up to nearly 90p. It is probably those shareholders now selling.... Having said that, still a good company with potential value if you take at least a 5 year view.
06/4/2020
18:23
lammylover: Share price at 64p is WAY BELOW the share price reached when they announced the last results being ahead of expectations - price then rose to 72p. It appears that there is still a large seller selling off blocks of shares into any share price rise and effectively keeping the price down. But also there are lots of large buys going through sub 66p. At current price of 64p, there is nothing factored in for the £5m order from NHS received in March. Quite why the large seller is offloading, is anyone's guess? All I can say is that the next update on results should be around 20th April (based on last 2 years RNS trade updates) and I can't see it being anything but positive. Even if the NHS ventilators are still in transit, we know the order is good and its almost certain that other orders from NHS and other countries since the CV outbreak will be significantly larger than normal. Summary = absolute bargain at 64p; however its a crazy market out there!! Rich
03/4/2020
08:36
lammylover: IHC year share price range is 57.1p to 89.9p. The share price reached 72.65p in January on RNS detailing year end information including "ahead of market expectations" results. Since then they have picked up a £4.0m order for ventillators from NHS. Share price rose to 89.9p on this news. Subsequently price has slipped back on low volume and no news. This company supplies all manner of medical supplies, not just ventillators. At this time of unprecedented demand, why on earth would you think that sales would fall and share price be at 50p??? You should do yourself a favour and buy today at 64.5p and thank me when the results come in! Rich
Inspiration Healthcare share price data is direct from the London Stock Exchange
ADVFN Advertorial
Your Recent History
LSE
IHC
Inspiratio..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20200815 18:04:13